書誌事項
- タイトル別名
-
- Anti-high Mobility Group Box-1 Antibody Therapy for Traumatic Brain Injury
- Symposium Review 外傷性脳傷害に対する抗HMGB-1抗体治療
- Symposium Review ガイショウセイ ノウ ショウガイ ニ タイスル コウHMGB-1 コウタイ チリョウ
この論文をさがす
抄録
Traumatic brain injury (TBI) is one of the major causes of death and aftereffects in young individuals worldwide; however, efficient therapies for TBI are lacking at present. High mobility group box-1 (HMGB-1), which is recognized as a representative of danger-associated molecular patterns (DAMPs), plays an important role in triggering inflammatory responses in many types of diseases. We presented the involvement of HMGB-1 in TBI and evaluated the ability of intravenously administered neutralizing anti-HMGB-1 monoclonal antibody (mAb) to attenuate brain injury. Anti-HMGB-1 mAb may provide a novel and effective therapy for TBI by protecting against blood brain barrier disruption and reducing the inflammatory responses induced by HMGB-1.<br>
収録刊行物
-
- 薬学雑誌
-
薬学雑誌 134 (6), 701-705, 2014-06-01
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282681104109952
-
- NII論文ID
- 130004427993
-
- NII書誌ID
- AN00284903
-
- COI
- 1:STN:280:DC%2BC2cjot1Gquw%3D%3D
-
- ISSN
- 13475231
- 00316903
-
- NDL書誌ID
- 025583263
-
- PubMed
- 24882644
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可